Cencora, Inc.
CORStock
$307.99+0.65%52W
Market Cap$57.70B
P/E37.13x
Div yield0.81%
Beta0.58
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-22.34%
Price vs S&P 500 (4W)4.77%
VGM Score52.39
Market Capitalization$57.70B
P/E Ratio (Annual)37.13x
Indicated Dividend Yield (Annual)0.81%
Earnings Surprise History
Q2 264.75est. 4.86
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.06
4.00
4.05
4.00
Industry Peers — Drug Wholesale(9)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CORCencora, Inc. | D | B | C | $307.99 |
| MCKMcKesson Corporation | D | B | C | $841.31 |
| CAHCardinal Health, Inc. | D | C | B | $228.72 |
| HLFHerbalife Ltd. | B | D | C | $12.37 |
| NUSNuSkin Enterprises, Inc. | A | F | F | $5.39 |
| COSMCosmos Holdings Inc. Common Stock | D | B | D | $0.28 |
| HWHHWH International Inc. Common Stock | F | F | C | $1.20 |
| WGRXWellgistics Health, Inc. Common Stock | D | F | F | $2.66 |
| HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares | — | F | D | $0.43 |
| ZSTKZeroStack Corp. Common Stock | — | F | F | $1.87 |
About
Cencora is one of three dominant pharmaceutical wholesalers in the US, distributing branded, generic, and specialty drugs to pharmacies, hospitals, and healthcare providers. The company and its two main competitors control over 90% of the US pharmaceutical wholesale market. Beyond core distribution, Cencora generates revenue through commercialization services for pharmaceutical and medical device manufacturers, specialty logistics (World Courier), and animal health distribution (MWI Animal Health). The company strengthened its international footprint through the 2021 acquisition of Alliance Healthcare, a leading European pharmaceutical wholesaler.